in each case , the groups receiving and not receiving furosemide did not differ in mean age , initial creatinine , duration of aminoglycoside therapy , mean change in auditory acuity or creatinine , mean number of days to the development of toxicity , the frequency with which gentamicin , tobramycin , amikacin , or cephalothin was administered , or the mean predose and 1-h postdose plasma aminoglycoside levels .
C0002556
aminoglycoside
C0040341
tobramycin